Evolution in quality of life and epidemiological impact after endovascular treatment of chronic cerebro-spinal venous insufficiency in patients with multiple sclerosis.
BACKGROUND
We report the outcome of 67 patients after endovascular treatment of chronic cerebro-spinal venous insufficiency in patients with multiple sclerosis.  Material and methods For evaluating outcome, patients were divided into three groups with respective outcome after three, six and twelve months. Assessment of outcome was done by a disease-specific quality-of-life score that reflects the physical health (physical health composite, PHC) and mental health (mental health composite, MHC) by a score.


RESULTS
Improvement in PHC was significant (P < 0.05) in the three- and six-month groups. Improvement in MHC was only significant (P < 0.05) in the three-month group.


CONCLUSIONS
In conclusion, we can state that the result of endovascular treatment seems to decay although the baseline is still higher than preoperative. To confirm this finding, this study needs to be reproduced in a larger patient population.
Department of Cardiovascular and Thoracic Surgery, OLV Hospital, Moorselbaan 164 9300 Aalst, Belgium. roel.beelen@olvz-aalst.be
R
R
Beelen
L
L
Maene
P
P
Castenmiller
V
V
Decoene
I
I
Degrieck
D000328:Adult; D002550:Cerebral Veins; D057510:Endovascular Procedures; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008603:Mental Health; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000196:embryology / Q000523:psychology / Q000628:therapy; D011788:Quality of Life; D012189:Retrospective Studies; D013131:Spine / Q000098:blood supply*; D014689:Venous Insufficiency / Q000453:epidemiology / Q000209:etiology / Q000523:psychology / Q000628:therapy